Skip to main content
Erschienen in: Diabetologia 9/2018

24.05.2018 | Article

Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes

verfasst von: Raija Lithovius, Daniel Gordin, Carol Forsblom, Markku Saraheimo, Valma Harjutsalo, Per-Henrik Groop, on behalf of the FinnDiane Study Group

Erschienen in: Diabetologia | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

This study aimed to assess the use of ambulatory BP monitoring (ABPM) to identify the presence of masked, nocturnal and white-coat hypertension in individuals with type 1 diabetes, patterns that could not be detected by regular office-based BP monitoring alone. We also analysed associations between BP patterns and arterial stiffness in order to identify individuals at cardiovascular risk.

Methods

This substudy included 140 individuals with type 1 diabetes from the Helsinki metropolitan area, who attended the Finnish Diabetic Nephropathy Study (FinnDiane) Centre in Helsinki between January 2013 and August 2017. Twenty-four hour ABPM and pulse wave analysis were performed simultaneously using a validated non-invasive brachial oscillometric device (Mobil-O-Graph). Definitions of hypertension were based on the European Society of Hypertension guidelines. Masked hypertension was defined as normal office BP (BP obtained using a standardised automated BP device) but elevated 24 h ABPM, and white-coat hypertension as elevated office BP but normal 24 h ABPM.

Results

A total of 38% of individuals were normotensive and 33% had sustained hypertension, while 23% had masked and 6% had white-coat hypertension. About half of the cohort had increased absolute levels of night-time BP, half of whom were untreated. In the ambulatory setting, central BP and pulse wave velocity (PWV) were higher in participants with masked hypertension than in those with normotension (p ≤ 0.001). In a multivariable linear regression model adjusted for age, sex, BMI, antihypertensive treatment and eGFR, masked hypertension was independently associated with higher 24 h PWV (β 0.50 [95% CI 0.34, 0.66]), but not with PWV obtained during resting conditions (adjusted β 0.28 [95% CI −0.53, 1.10]), using normotension as the reference group.

Conclusions/interpretation

ABPM analysis revealed that one-quarter of the participants with type 1 diabetes had masked hypertension; these individuals would not have been detected by office BP alone. Moreover, arterial stiffness was increased in individuals with masked hypertension. These findings support the use of ABPM to identify individuals at risk of cardiovascular disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144–148CrossRefPubMed Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144–148CrossRefPubMed
2.
Zurück zum Zitat Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ (2000) Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159–169CrossRefPubMed Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ (2000) Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159–169CrossRefPubMed
3.
Zurück zum Zitat Lithovius R, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH, on behalf of the FinnDiane Study Group (2014) Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy. Diabetes Care 37:709–717CrossRefPubMed Lithovius R, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH, on behalf of the FinnDiane Study Group (2014) Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy. Diabetes Care 37:709–717CrossRefPubMed
4.
Zurück zum Zitat Mancia G, Verdecchia P (2015) Clinical value of ambulatory blood pressure: evidence and limits. Circ Res 116:1034–1045CrossRefPubMed Mancia G, Verdecchia P (2015) Clinical value of ambulatory blood pressure: evidence and limits. Circ Res 116:1034–1045CrossRefPubMed
5.
Zurück zum Zitat Solak Y, Kario K, Covic A et al (2016) Clinical value of ambulatory blood pressure: is it time to recommend for all patients with hypertension? Clin Exp Nephrol 20:14–22CrossRefPubMed Solak Y, Kario K, Covic A et al (2016) Clinical value of ambulatory blood pressure: is it time to recommend for all patients with hypertension? Clin Exp Nephrol 20:14–22CrossRefPubMed
6.
Zurück zum Zitat Hodgkinson J, Mant J, Martin U et al (2011) Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 342:d3621CrossRefPubMedPubMedCentral Hodgkinson J, Mant J, Martin U et al (2011) Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 342:d3621CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Lazaridis AA, Sarafidis PA, Ruilope LM (2015) Ambulatory blood pressure monitoring in the diagnosis, prognosis, and management of resistant hypertension: still a matter of our resistance? Curr Hypertens Rep 17:78CrossRefPubMed Lazaridis AA, Sarafidis PA, Ruilope LM (2015) Ambulatory blood pressure monitoring in the diagnosis, prognosis, and management of resistant hypertension: still a matter of our resistance? Curr Hypertens Rep 17:78CrossRefPubMed
8.
Zurück zum Zitat Pickering TG, Davidson K, Gerin W, Schwartz JE (2002) Masked hypertension. Hypertension 40:795–796CrossRefPubMed Pickering TG, Davidson K, Gerin W, Schwartz JE (2002) Masked hypertension. Hypertension 40:795–796CrossRefPubMed
9.
Zurück zum Zitat O’Brien E, Parati G, Stergiou G et al (2013) European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31:1731–1768CrossRefPubMed O’Brien E, Parati G, Stergiou G et al (2013) European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31:1731–1768CrossRefPubMed
10.
Zurück zum Zitat Franklin SS, Thijs L, Li Y et al (2013) Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 61:964–971CrossRefPubMedPubMedCentral Franklin SS, Thijs L, Li Y et al (2013) Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 61:964–971CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat George B, Bantwal G, Ayyar V, Mathew V (2015) Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls. J Diabetes Sci Technol 9:138–144CrossRefPubMed George B, Bantwal G, Ayyar V, Mathew V (2015) Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls. J Diabetes Sci Technol 9:138–144CrossRefPubMed
12.
Zurück zum Zitat Theilade S, Lajer M, Persson F, Joergensen C, Rossing P (2013) Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care 36:715–721CrossRefPubMedPubMedCentral Theilade S, Lajer M, Persson F, Joergensen C, Rossing P (2013) Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care 36:715–721CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Nilsson PM, Lurbe E, Laurent S (2008) The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 26:1049–1057CrossRefPubMed Nilsson PM, Lurbe E, Laurent S (2008) The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens 26:1049–1057CrossRefPubMed
14.
Zurück zum Zitat Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH, Finnish Diabetic Nephropathy (FinnDiane) Study Group (2004) Altered age-related blood pressure pattern in type 1 diabetes. Circulation 110:1076–1082CrossRefPubMed Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH, Finnish Diabetic Nephropathy (FinnDiane) Study Group (2004) Altered age-related blood pressure pattern in type 1 diabetes. Circulation 110:1076–1082CrossRefPubMed
15.
Zurück zum Zitat Gordin D, Waden J, Forsblom C et al (2011) Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (the FinnDiane study). Diabetes Care 34:886–891CrossRefPubMedPubMedCentral Gordin D, Waden J, Forsblom C et al (2011) Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (the FinnDiane study). Diabetes Care 34:886–891CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Takeno K, Mita T, Nakayama S et al (2012) Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens 25:165–170CrossRefPubMed Takeno K, Mita T, Nakayama S et al (2012) Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens 25:165–170CrossRefPubMed
17.
Zurück zum Zitat Omboni S, Posokhov IN, Kotovskaya YV, Protogerou AD, Blacher J (2016) Twenty-four-hour ambulatory pulse wave analysis in hypertension management: current evidence and perspectives. Curr Hypertens Rep 18:72CrossRefPubMed Omboni S, Posokhov IN, Kotovskaya YV, Protogerou AD, Blacher J (2016) Twenty-four-hour ambulatory pulse wave analysis in hypertension management: current evidence and perspectives. Curr Hypertens Rep 18:72CrossRefPubMed
18.
Zurück zum Zitat Thorn LM, Forsblom C, Fagerudd J et al (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019–2024CrossRefPubMed Thorn LM, Forsblom C, Fagerudd J et al (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019–2024CrossRefPubMed
19.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hametner B, Wassertheurer S, Kropf J, Mayer C, Eber B, Weber T (2013) Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements. Blood Press Monit 18:173–176CrossRefPubMed Hametner B, Wassertheurer S, Kropf J, Mayer C, Eber B, Weber T (2013) Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements. Blood Press Monit 18:173–176CrossRefPubMed
21.
Zurück zum Zitat Weiss W, Gohlisch C, Harsch-Gladisch C, Tolle M, Zidek W, van der Giet M (2012) Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit 17:128–131CrossRefPubMed Weiss W, Gohlisch C, Harsch-Gladisch C, Tolle M, Zidek W, van der Giet M (2012) Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit 17:128–131CrossRefPubMed
22.
Zurück zum Zitat Feistritzer HJ, Reinstadler SJ, Klug G et al (2015) Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity. PLoS One 10:e0116862CrossRefPubMedPubMedCentral Feistritzer HJ, Reinstadler SJ, Klug G et al (2015) Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity. PLoS One 10:e0116862CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366CrossRefPubMed Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366CrossRefPubMed
24.
Zurück zum Zitat Hansen TW, Thijs L, Li Y et al (2010) Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 55:1049–1057CrossRefPubMed Hansen TW, Thijs L, Li Y et al (2010) Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 55:1049–1057CrossRefPubMed
25.
Zurück zum Zitat Wilkinson IB, Fuchs SA, Jansen IM et al (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084CrossRefPubMed Wilkinson IB, Fuchs SA, Jansen IM et al (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16:2079–2084CrossRefPubMed
26.
Zurück zum Zitat Franklin SS, O’Brien E, Thijs L, Asayama K, Staessen JA (2015) Masked hypertension: a phenomenon of measurement. Hypertension 65:16–20CrossRefPubMed Franklin SS, O’Brien E, Thijs L, Asayama K, Staessen JA (2015) Masked hypertension: a phenomenon of measurement. Hypertension 65:16–20CrossRefPubMed
27.
Zurück zum Zitat Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, Esteves JF, Gross JL (2010) Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract 87:240–245CrossRefPubMed Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, Esteves JF, Gross JL (2010) Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract 87:240–245CrossRefPubMed
28.
Zurück zum Zitat Mateo-Gavira I, Vilchez-Lopez FJ, Garcia-Palacios MV, Carral-San Laureano F, Jimenez-Carmona S, Aguilar-Diosdado M (2016) Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complicat 30:1326–1332CrossRefPubMed Mateo-Gavira I, Vilchez-Lopez FJ, Garcia-Palacios MV, Carral-San Laureano F, Jimenez-Carmona S, Aguilar-Diosdado M (2016) Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complicat 30:1326–1332CrossRefPubMed
29.
Zurück zum Zitat Head GA, Mihailidou AS, Duggan KA et al (2010) Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 340:c1104CrossRefPubMedPubMedCentral Head GA, Mihailidou AS, Duggan KA et al (2010) Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 340:c1104CrossRefPubMedPubMedCentral
30.
31.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71:e13–e115 Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71:e13–e115
32.
Zurück zum Zitat Drawz PE, Pajewski NM, Bates JT et al (2017) Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension 69:42–50CrossRefPubMed Drawz PE, Pajewski NM, Bates JT et al (2017) Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension 69:42–50CrossRefPubMed
33.
Zurück zum Zitat Gordin D, Waden J, Forsblom C et al (2012) Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) study. Ann Med 44:196–204CrossRefPubMed Gordin D, Waden J, Forsblom C et al (2012) Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) study. Ann Med 44:196–204CrossRefPubMed
34.
Zurück zum Zitat Luzardo L, Lujambio I, Sottolano M et al (2012) 24-H ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study. Hypertens Res 35:980–987CrossRefPubMed Luzardo L, Lujambio I, Sottolano M et al (2012) 24-H ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study. Hypertens Res 35:980–987CrossRefPubMed
35.
Zurück zum Zitat Omboni S, Posokhov IN, Parati G et al (2016) Vascular health assessment of the hypertensive patients (VASOTENS) registry: study protocol of an international, web-based telemonitoring registry for ambulatory blood pressure and arterial stiffness. JMIR Res Protoc 5:e137CrossRefPubMedPubMedCentral Omboni S, Posokhov IN, Parati G et al (2016) Vascular health assessment of the hypertensive patients (VASOTENS) registry: study protocol of an international, web-based telemonitoring registry for ambulatory blood pressure and arterial stiffness. JMIR Res Protoc 5:e137CrossRefPubMedPubMedCentral
Metadaten
Titel
Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes
verfasst von
Raija Lithovius
Daniel Gordin
Carol Forsblom
Markku Saraheimo
Valma Harjutsalo
Per-Henrik Groop
on behalf of the FinnDiane Study Group
Publikationsdatum
24.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 9/2018
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4648-5

Weitere Artikel der Ausgabe 9/2018

Diabetologia 9/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.